Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2002
12/27/2002WO2002102401A1 Treatment of dementia and neurodegenerative diseases with intermediate doses of lhrh antagonists
12/27/2002WO2002102399A2 Mucosal repair by tff2 peptides
12/27/2002WO2002102394A2 Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancer, diabetes, premenstrual syndrome and transdermal transport
12/27/2002WO2002102393A1 Composition for treating varicosity and method of preparation thereof
12/27/2002WO2002102392A1 Use of adenosine a1 receptor agonists for the treatment of nociceptive pain
12/27/2002WO2002102391A2 Composition comprising nanoparticulate spironolactone
12/27/2002WO2002102390A1 Enhanced drug delivery in transdermal systems
12/27/2002WO2002102389A1 3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure
12/27/2002WO2002102388A2 Active ingredient combination of e.g. galanthamine or deoxypeganine and e.g. acamprosate or memantine for treating an addiction such as alcoholism
12/27/2002WO2002102387A1 Treatment of neuropathic pain
12/27/2002WO2002102386A1 Methods and pharmaceuticals for treating muscle insulin resistance and related conditions
12/27/2002WO2002102385A1 Compositions comprising cgmppde5 inhibitor for transdermal delivery to the erectile tissue of the penis
12/27/2002WO2002102384A1 Antibacterial treatment of osteoarthritis
12/27/2002WO2002102383A1 Aqueous cilostazol preparation for injection
12/27/2002WO2002102382A1 A PROCESS FOR PREPARING PAROXETINE HCl WHICH LIMITS FORMATION OF PINK COLORED COMPOUNDS
12/27/2002WO2002102381A1 Acylic piperazine and piperidine derivatives which are useful for treating neuronal damage
12/27/2002WO2002102380A1 Monocyclic or bicyclic carbocycles and heterocycles as factor xa inhibitors
12/27/2002WO2002102379A1 Sophoridine and use thereof as an analgesic
12/27/2002WO2002102378A1 Therapeutic treatment for sexual dysfunction
12/27/2002WO2002102377A1 Immune response modifiers for the treatment of periodontal disease
12/27/2002WO2002102376A1 ORALLY DELIVERABLE PHARMACEUTICAL COMPOSITION COMPRISING AN ACTIVE COMPOUND HAVING AN AMINOSULFONYL GROUP (cox-2 INHIBITOR), A POLYETHYLENE GLYCOL AND A FREE-RADICAL SCAVENGING ANTIOXIDANT
12/27/2002WO2002102375A2 Imidazole derivatives for modulating sodium channels
12/27/2002WO2002102373A1 Method for administration of cancer therapeutic
12/27/2002WO2002102370A1 Biofilm degrading or sloughing compositions and methods
12/27/2002WO2002102369A2 Agent for protection of retinal neurons
12/27/2002WO2002102368A1 Mass cell production method of chondrocytes, using an erk activity inhibitor, and a screening method therefor
12/27/2002WO2002102367A1 Pharmaceutical composition for prevention and treatment of joint arthritis and a screening method thereof
12/27/2002WO2002102366A1 Parasiticides for farmed fish
12/27/2002WO2002102365A1 Tricyclic terpenes of the family of abietic acid as rantes receptor ligands
12/27/2002WO2002102364A1 Pparg agonistic medicinal compositions
12/27/2002WO2002102363A1 Biological response modifier composition and uses thereof
12/27/2002WO2002102362A1 Dietetic preparation and use of an alpha-hydroxy carboxylic acid (citric acid for the treatment of obesity
12/27/2002WO2002102361A1 Remedies for diseases caused by nonsense mutation
12/27/2002WO2002102360A2 Compositions based on branched chain amino acids for improving the myocardial ventricular function in patients suffering from diabetes
12/27/2002WO2002102359A2 Alkylidene pyrazolidinedione derivatives and use for treating diabetes and obesity
12/27/2002WO2002102357A1 A coated nicotine-containing chewing gum, manufacture and use thereof
12/27/2002WO2002102354A1 Lymphatic drug delivery system
12/27/2002WO2002102346A1 Use of at least one 10-hydroxy-2-decenoic acid derivative in compositions for treating the cutaneous signs of ageing
12/27/2002WO2002102344A2 No-synthase inhibitor and use thereof
12/27/2002WO2002102343A1 Ascorbyl 2-hexadecanoate as a no-synthase inhibitor
12/27/2002WO2002102340A2 Use of carnitine and/or one or more acyl-carnitines for producing cosmetic or dermatological preparations
12/27/2002WO2002102338A1 Carnitine and acyl-carnitines used in the treatment and prophylaxis of pigmentation disorders
12/27/2002WO2002102325A2 Plasma glucosylceramide deficiency as risk factor for thrombosis and modulator of anticoagulant protein c
12/27/2002WO2002102317A2 Treatment of respiratory conditions associated with bronchoconstriction with aerosolized hyaluronic acid
12/27/2002WO2002102315A2 QUINAZOLINE AND PYRIDO[2,3-d]PYRIMIDINE INHIBITORS OF PHOSPHODIESTERASE (PDE) 7
12/27/2002WO2002102314A2 Purine inhibitors of phosphodiesterase (pde) 7
12/27/2002WO2002102313A2 Pyrimidine inhibitors of phosphodiesterase (pde) 7
12/27/2002WO2002102311A2 Nanoparticles for treating targeted tissues and cells
12/27/2002WO2002102307A2 Nucleoside vaccine adjuvants
12/27/2002WO2002102306A2 Methods and compositions for inhibiting, preventing, or reducing tumor cell growth in patients resistant to the antineoplastic effects of antiestrogen therapy
12/27/2002WO2002102304A2 Gum resin as a carrier for topical application of pharmacologically active agents
12/27/2002WO2002102301A2 Substituted indole-2-carboxylic acid benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof
12/27/2002WO2002102298A2 Process for the preparation of dispersions
12/27/2002WO2002102297A2 Use of cox-2 inhibitors for the treatment of schizophrenia, delusional disorders, affective disorders, autism or tic disorders
12/27/2002WO2002102232A2 A novel signaling pathway for the production of inflammatory pain and neuropathy
12/27/2002WO2002102229A2 Diagnosing tumorigenicity and determining resistance to anticancer therapy
12/27/2002WO2002102169A2 Synthetic fat composition
12/27/2002WO2002102163A1 Method and composition for enhancing sexual desire
12/27/2002WO2002102155A1 Amenoacetonitrile compounds for controlling endoparasites
12/27/2002WO2002092565A3 3-aminoalkyl-2-aryl-indole derivatives and their use as gnrh antagonists
12/27/2002WO2002088127A3 Triazolopyrimidines
12/27/2002WO2002087567A3 Polymethoxylated flavones for treating insulin resistance
12/27/2002WO2002083696A3 Novel cyclo azaphospha hydrocarbons
12/27/2002WO2002083139B1 Inhibitors of akt activity
12/27/2002WO2002083136A8 Therapeutic compositions comprising amino sulfonic acids and their uses
12/27/2002WO2002081664A3 Use of nucleosides, nucleobases and derivatives thereof for improved production of adult stem cells
12/27/2002WO2002076946A3 Fused pyridine derivatives for use as vanilloid receptor antagonists for treating pain.
12/27/2002WO2002074776A3 Highly purified and crystalline form of harringtonine
12/27/2002WO2002072077A3 Use of amino acids, amino acid analogues, sugar phosphates and sugar phosphate analogues for treatment of tumors, treatment of sepsis and immunosuppression
12/27/2002WO2002072072A3 Granules and granules coated with a masked taste
12/27/2002WO2002072047A3 Cosmetic or pharmaceutical agent
12/27/2002WO2002070473A3 Carboxamide derivatives as therapeutic agents
12/27/2002WO2002069911A3 Active substance combination consisting of $g(a)-liponic acid and bioquinones
12/27/2002WO2002069888A3 Serotonin reuptake inhibitor formulations
12/27/2002WO2002066072A9 Methods for the treatment and diagnosis of prostate cancer based on p75ntr tumor
12/27/2002WO2002064618A3 Methods of identifying agents that mediate polypeptide aggregation
12/27/2002WO2002062335A3 Implantable device containing resorbable matrix material and anti-proliferative drugs for preventing or treating failure of hemodialysis vascular access and other vascular grafts
12/27/2002WO2002060922A3 Epoxyvibsanin b
12/27/2002WO2002060454A3 Use of dinucleoside polyphosphate to stimulate removal of fluid in retinal disorders
12/27/2002WO2002058668A3 Artificial tear composition adapted to be used with contact lenses
12/27/2002WO2002058666A3 Process for preparing non-hygroscopic sodium valproate composition
12/27/2002WO2002057302A3 A virus causing respiratory tract illness in susceptible mammals
12/27/2002WO2002056888A3 Assay method, tnf modulator and its use
12/27/2002WO2002056874A3 Lipid-based nitric oxide donors
12/27/2002WO2002055720A9 Materials and methods relating to protein aggregation in neurodegenerative disease
12/27/2002WO2002055087B1 Dihydro-triterpenes in the treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain
12/27/2002WO2002053142A3 Compositions and methods for enhancing cytokine activity and treating hypotension associated with the administration of cytokines
12/27/2002WO2002051994A3 Polypeptides
12/27/2002WO2002051420A3 Methods and formulations for the treatment of female sexual dysfunction
12/27/2002WO2002051400A3 Solid dosage forms of divalproex sodium
12/27/2002WO2002049593A3 Use of dna repair enzymes as mmp-1 inhibitors
12/27/2002WO2002046181A3 Abca-1 elevating compounds against coronary artery disease or atherosclerosis
12/27/2002WO2002045695A3 Hydrostatic delivery system for controlled delivery of agent
12/27/2002WO2002011712A3 Combination of huperzine and nicotinic compounds as a neuroprotective agent
12/27/2002WO2002009702A3 Use of indole derivatives for the manufacture of a medicament for reducing intracular pressure
12/27/2002WO2002005851A8 Enhancement of the action of central and peripheral nervous system agents
12/27/2002WO2002004623A3 ANTISENSE COMPOSITIONS TARGETED TO β1 ADRENOCEPTOR-SPECIFIC MRNA AND METHODS OF USE
12/27/2002WO2002002078A3 Improved liposomal camptothecins and uses thereof
12/27/2002WO2001097829A3 Combination enzyme replacement, gene therapy and small molecule therapy for lysosomal storage diseases
12/27/2002WO2001091856A3 Use of cox2 inhibitors for treating skin injury from exposure to ultraviolet radiation
1 ... 5608 5609 5610 5611 5612 5613 5614 5615 5616 5617 5618 5619 5620 5621 5622 5623 5624 5625 5626 5627 5628 ... 7860